Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Randall Stanicky
Pharma
Viatris, or just Mylan with a new name? Analysts say latter
After Viatris laid out its financial targets for the first time as a combined company, analysts questioned its revenue and cash generation plans.
Angus Liu
Mar 12, 2021 12:09pm
Pfizer's Ibrance fails early breast cancer trial
May 30, 2020 5:41pm
Allergan preparing to split after years of turmoil: analyst
Jun 19, 2019 10:50am
IRS knocks Perrigo for $873M in unpaid royalties
Apr 30, 2019 12:38pm
When is a ph3 flop a good thing? Just ask Allergan's investors
Mar 7, 2019 11:53am
Could Mylan swing a sale to private equity buyer?
Sep 21, 2018 11:27am
